Physician profile
Austyn Otten
NPI 1831782366
$5,701.36
in general payments reported to CMS, 2019-2025
25 companies · $1,002 in 2025
The $1,002 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $894 · 2023: $1,648 · 2024: $2,038 · 2025: $1,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,517 · Food and Beverage: $2,113 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31.00 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,516.61 |
| Food and Beverage | $2,112.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31.00 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,668.90 | 2024 | Axonics |
| Medtronic, INC. | $1,532.48 | 2023-2025 | Interstim, Nuro |
| Abbvie INC. | $324.91 | 2022-2023 | |
| Astrazeneca Pharmaceuticals Lp | $262.03 | 2022-2025 | Lynparza |
| Tempus Ai, INC | $233.97 | 2025 | Xt Cdx |
| Teleflex LLC | $211.51 | 2025 | Barrigel |
| Olympus America INC. | $203.54 | 2023-2025 | Itind System |
| Lilly USA, LLC | $187.33 | 2021-2023 | Mounjaro |
| Telix Pharmaceuticals | $166.36 | 2025 | Illuccix |
| Novo Nordisk INC | $125.06 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.68 | 2021-2022 | |
| Bioprotect Medical, INC. | $93.05 | 2024 | Bioprotect Balloon Implant System |
| Amgen INC. | $92.40 | 2022-2023 | Evenity, Prolia |
| Boston Scientific Corporation | $75.42 | 2025 | Bulkamid |
| Sanofi-Aventis U.S. LLC | $69.03 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $63.67 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $60.87 | 2025 | Provenge |
| Procept Biorobotics Corporation | $54.39 | 2025 | |
| Xeris Pharmaceuticals, INC. | $51.17 | 2022-2023 | Keveyis |
| Sumitomo Pharma America, INC. | $31.00 | 2024 | Gemtesa |
| Calyxo, INC. | $26.99 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $24.55 | 2022 | |
| Exact Sciences Corporation | $17.12 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $15.32 | 2022 | |
| Mylan Specialty L.P. | $14.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austyn Otten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.